期刊
PHYTOMEDICINE
卷 20, 期 13, 页码 1160-1167出版社
ELSEVIER GMBH, URBAN & FISCHER VERLAG
DOI: 10.1016/j.phymed.2013.06.004
关键词
TGF-beta; Lycopus lucidus; Smad; renal disease
资金
- National Natural Science Foundation of China [81274150, 81202967]
- Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine
Purpose Renal fibrosis characterized by accumulation of extracellular matrix protein results in chronic renal diseases including diabetic nephropathy. Transforming growth factor beta 1 (TGF-beta 1) signaling pathway plays a key role in mediating renal fibrosis. Hence, agents that antagonize TGF-beta signaling could be candidate for kidney disease therapy. Methods We established renal fibrosis model both in vitro with fibroblast cells treated with rhTGF-beta 1 and streptozocin(STZ)-induced diabetic nephropathy rats model in vivo and evaluated the effect of the aqueous extract of Lycopus lucidus Turcz, the blood-circulation-promoting Chinese herb, on diabetic nephropathy and investigated the mechanism of action. Results We found that Lycopus suppressed rhTGF-beta 1-induced Smad2 and ERK1/2 activation, down-regulated the expression of TGF-beta RI, TGF-beta RII, Smad4 and Smad7 in SV40 MES13 cells without inhibiting cell viability. In vivo, lycopus inhibited Smad2 phosphorylation, reduced mRNA level of TGF-beta 1, ameliorated expansion of the mesangial area in glomerular tissue and reduced the levels of Scr and BUN of serum and total-SOD (superoxide dismutase) activity in STZ-induced diabetic rats. Conclusion Lycopus is a novel inhibitor of renal fibrosis by blocking TGF-beta signaling pathway and possess a protective effect on renal damage of STZ-induced diabetic nephropathy in rats. (C) 2013 Elsevier GmbH. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据